Barbiturates can induce hepatic microsomal enzymes leading to increased metabolism and reduced anticoagulant response of oral anticoagulants (eg, warfarin, acenocoumarol, dicumarol, and phenprocoumon); individuals stabilized on anticoagulant therapy may well need dosage changes if barbiturates are added to or withdrawn from their dosage routinepent